Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway - Concepedia

Concepedia

Publication | Open Access

Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway

DOI Full Paper Access

39

Citations

23

References

2016

Year

Zhenhua Wu, Lin Chen, Mingming Liu, Jian Zhang, Zhonghua Tao, Xichun Hu

Abstract

In highly gemcitabine-resistant 231 cells, src inhibition can synergize with gemcitabine, reverse drug resistance, inhibit tumor growth/metastasis/stemness of cancer stem cells, possibly via the AKT/c-Jun pathway.

References

	Year	Citations

Page 1